Natraj Proteins Share Price
41.79+1.16 (+2.86%)
+4.06% past 1 Year
Natraj Proteins Limited is an India-based company. The Company operates in two segments: Solvent Extraction Unit and Wind Mill. It principal products include solvent extracted crude oil, solvent extracted meal
Corporate filings & documents
Announcements
Submission of newspaper advertisement publication related to extract of quarterly Un-audited financial results of the company for the quarter ended 30th June 2026.
2 weeks agoSubmission of newspaper advertisement publication related to extract of quarterly Un-audited financial results of the company for the quarter ended 30th June 2026.
2 weeks agoRe-appointment of Shri Sharad Kumar Jain (DIN: 02757935) as the Whole Time Director of the Company for a further period of 3 years w.e.f. 1st October 2026 subject to approval of members at the ensuing Annual General Meeting.
3 weeks agoRe-appointment of Shri Sharad Kumar Jain (DIN: 02757935) as the Whole Time Director of the Company for a further period of 3 years w.e.f. 1st October 2026 subject to approval of members at the ensuing Annual General Meeting.
3 weeks agoAppointment of the Cost Auditor of the Company for the Financial Year 2026-27.
3 weeks agoAppointment of the Cost Auditor of the Company for the Financial Year 2026-27.
3 weeks agoWe are pleased to submit the Un-audited financial results along with limited review report for the Quarter ended 30th June 2026.
3 weeks agoWe are pleased to submit the Un-audited financial results along with limited review report for the Quarter ended 30th June 2026.
3 weeks agoWe are pleased to submit the outcome of 03/2026-27 meeting of Board of Directors held on 13th August 2026 as per Regulation 30 of SEBI (LODR) Regulation 2015 for approval of Un-audited financial results along with Limited Review Report by the statutory auditor of the company for the quarter ended 30th June 2026 along with other routine business..
3 weeks agoWe are pleased to submit the outcome of 03/2026-27 meeting of Board of Directors held on 13th August 2026 as per Regulation 30 of SEBI (LODR) Regulation 2015 for approval of Un-audited financial results along with Limited Review Report by the statutory auditor of the company for the quarter ended 30th June 2026 along with other routine business..
3 weeks agoNatraj Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve the following businesses: 1. Approval of the un-audited financial results of the company for the quarter ended 30th June 2026. 2. To take on record the limited review report by the auditors for the unaudited financial results of the company for the quarter ended 30th June 2026. 3. Other routine business items.
3 weeks agoNatraj Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve the following businesses: 1. Approval of the un-audited financial results of the company for the quarter ended 30th June 2026. 2. To take on record the limited review report by the auditors for the unaudited financial results of the company for the quarter ended 30th June 2026. 3. Other routine business items.
3 weeks agoCertificate for compliance of Regulation 74(5) of the SEBI (DP) Regulations 2018 for the Quarter ended 30th June 2026
1 month agoCertificate for compliance of Regulation 74(5) of the SEBI (DP) Regulations 2018 for the Quarter ended 30th June 2026
1 month agoThe window for trading in shares of the company shall remain close from 1st July 2026 till the completion of 48 hours after declaration of Quarterly Un-audited financial results of the company.
2 months agoThe window for trading in shares of the company shall remain close from 1st July 2026 till the completion of 48 hours after declaration of Quarterly Un-audited financial results of the company.
2 months agoPursuant to Reg.24A of SEBI Listing Regulations and Master Circular issued by SEBI We are pleased to submit the Annual Secretarial Compliance report for the year ended on 31.03.2026
3 months agoPursuant to Reg.24A of SEBI Listing Regulations and Master Circular issued by SEBI We are pleased to submit the Annual Secretarial Compliance report for the year ended on 31.03.2026
3 months agoSubmission of newspaper advertisement publication related to extract of Quarterly/yearly Audited financial results of the Company for the Quarter and Year ended 31st March 2026
3 months agoSubmission of newspaper advertisement publication related to extract of Quarterly/yearly Audited financial results of the Company for the Quarter and Year ended 31st March 2026
3 months agoWe are pleased to submit the audited financial result for the quarter/year ended on 31.03.2026 alongwith Statement of Assets and Liabilities and Cash Flow.
3 months agoWe are pleased to submit the audited financial result for the quarter/year ended on 31.03.2026 alongwith Statement of Assets and Liabilities and Cash Flow.
3 months agowe are pleased to submit the Audited Financial Results along with Statement of Assets and Liabilities and Cash Flow and Auditors Report thereon by Statutory Auditors for the Quarter/Year ended on 31st March 2026 in PDF Format which were approved by the Audit Committee and Board of Directors at their meeting held on Friday 22nd day of May 2026 at 4:00 P.M. and concluded at 6:15 P.M.
3 months agowe are pleased to submit the Audited Financial Results along with Statement of Assets and Liabilities and Cash Flow and Auditors Report thereon by Statutory Auditors for the Quarter/Year ended on 31st March 2026 in PDF Format which were approved by the Audit Committee and Board of Directors at their meeting held on Friday 22nd day of May 2026 at 4:00 P.M. and concluded at 6:15 P.M.
3 months agoNatraj Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 inter alia to consider and approve the following businesses along with other routine businesses: 1. To consider & approve the Audited financial results of the Company for the Quarter/Year ended 31st March 2026. 2. To take on record the Audit Report of the Statutory Auditors for the Audited Financial Results of the Company for the Quarter/Year ended 31st March 2026. 3. To consider and approve the Standalone Audited Financial Statements including the Balance Sheet as at 31st March 2026 and the Statement of Profits and Loss and Cash flow Statement of change in equity and notes thereon for the year ended 31st March 2026 4. Other Routine Business Items.
3 months agoNatraj Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 inter alia to consider and approve the following businesses along with other routine businesses: 1. To consider & approve the Audited financial results of the Company for the Quarter/Year ended 31st March 2026. 2. To take on record the Audit Report of the Statutory Auditors for the Audited Financial Results of the Company for the Quarter/Year ended 31st March 2026. 3. To consider and approve the Standalone Audited Financial Statements including the Balance Sheet as at 31st March 2026 and the Statement of Profits and Loss and Cash flow Statement of change in equity and notes thereon for the year ended 31st March 2026 4. Other Routine Business Items.
3 months agoRegistrar and Share Transfer agent of the Company M/S Ankit Consultancy Private Limited has dispatched the letter to the holders of physical securities related to mandatorily furnishing of KYC and Bank account details.
3 months agoRegistrar and Share Transfer agent of the Company M/S Ankit Consultancy Private Limited has dispatched the letter to the holders of physical securities related to mandatorily furnishing of KYC and Bank account details.
3 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Natraj Proteins Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L00153MP1990PLC006090</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>36.02</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Harshita Kirkire <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Abhinandan Prajapati <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 14/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Natraj Proteins Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L00153MP1990PLC006090</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>36.02</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Harshita Kirkire <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Abhinandan Prajapati <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 14/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoCertificate for compliance of Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations 2018 for the Quarter/Year ended 31st March 2026
5 months agoCertificate for compliance of Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations 2018 for the Quarter/Year ended 31st March 2026
5 months agoThe window for trading in shares of the Company shall remain close from 1st April 2026 till the completion of 48 hours after declaration of audited financial results of the company for the quarter and year ended 31st March 2026.
5 months agoThe window for trading in shares of the Company shall remain close from 1st April 2026 till the completion of 48 hours after declaration of audited financial results of the company for the quarter and year ended 31st March 2026.
5 months agoSubmission of newspaper advertisement related to opening of another special window for re-lodgement of transfer requests of physical shares.
5 months agoSubmission of newspaper advertisement related to opening of another special window for re-lodgement of transfer requests of physical shares.
5 months agoSubmission of newspaper advertisement publication related to extract of Quarterly/Nine months Unaudited Financial Results of the Company for the Quarter/Nine Months ended 31st December 2025.
6 months agoPursuant to regulation 33 of SEBI(LODR) 2015 we are pleased to submit the financial results for the Quarter/ Nine months ended 31st December 2025.
6 months agoPursuant to regulation 33 of SEBI(LODR) 2015 we are pleased to submit the financial results for the Quarter/ Nine months ended 31st December 2025.
6 months ago1. The Board of Directors Considered and approved the Standalone Un-audited Financial Results of the Company for the quarter/nine months ended 31st December 2025.2. The Board of Directors Considered and approved the Limited Review Report of the Statutory Auditors on the Standalone Un-audited Financial Results of the Company for the quarter/nine months ended 31st December 2025.
6 months ago1. The Board of Directors Considered and approved the Standalone Un-audited Financial Results of the Company for the quarter/nine months ended 31st December 2025.2. The Board of Directors Considered and approved the Limited Review Report of the Statutory Auditors on the Standalone Un-audited Financial Results of the Company for the quarter/nine months ended 31st December 2025.
6 months agoNatraj Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Natraj Proteins Limited has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve 1. Approval of the Un-Audited Financial Results of the Company for the Quarter and Nine months ended on 31st December 2025. 2. To take on record the Limited Review Report by the Auditors for the Un-Audited Financial Results of the Company for the Quarter and Nine months ended on 31st December 2025. 3. Other regulatory matters.
7 months agoCertificate for compliance of Regulation 74(5) of the SEBI(DP) Regulations 2018 for the quarter ending 31st December 2025
7 months agoThe window for trading in the shares of the company shall remain close from 1st January 2026 till the completion of 48 hours after declaration of unaudited financial results of the company for the quarter and nine months ended 31st December 2025
8 months agoSubmission of Press clipping related to extract of Quarterly/ Half- yearly Unaudited Fiancial Result of the Company for the Quarter/ Half year ended 30th September 2025
9 months agoWe are pleased to submit the Outcome of the Board Meeting held on 13/11/2025 for approval of the unaudited quarterly/half year financial statements for the quarter/half year ended on 30/09/2025 alongwith other routine matters.
9 months agoPursuant to Regulation 33 of SEBI(LODR) 2015 we are pleased to submit the Financial Results for the Qaurter and Half Year ended 30th September 2025.
9 months agoNatraj Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve the following businesses along with other routine businesses: 1. Approval of the Un-Audited Financial Results of the Company for the Quarter/ Half year ended 30th September 2025. 2. To take on Record the Limited Review Report by the Auditors for the Unaudited Financial Results of the Company for the Quarter/ Half year ended 30th September 2025. 3. Approval of the Un-Audited Statement of Assets and Liabilities for the Half year ended 30th September 2025; 4. Approval of the Un-Audited Statement of Cash Flow for the Half year ended 30th September 2025; and 5. Any other business.
10 months agoCertificate for Compliance of Regulation 74(5) of the SEBI (DP) Regulations 2018 for the Quarter ended 30th September 2025
10 months agoThe window for trading in the shares of the Company shall remain close from 1st October 2025 till the completion of 48 hours after declaration of unaudited financial results of the Company for the quarter and half year ended 30th September 2025.
11 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Ordinance Factory Road Nagpur - Kalan Itarsi Madhya Pradesh PIN: 461111 Tel No: 07572-262636-38 Fax No: 07572-262639 Email: [email protected] Internet: www.natrajproteins.com
Registrars
Plot No. 60, Electronic Complex, Pardeshipura, Indore (M.P.)-452010 Plot No 60 Electronic Complex Pardeshipura PIN: Tel No: NULL Fax No: NULL Email: NULL
Management
Harshita Kirkire, Company Secretary & Compliance Officer
Kailash Chand Sharma, Chairman & Managing Director
Kailash Chand Sharma, Chairman & Managing Director
Sharad Kumar Jain, Whole Time Director
Vishal Kumar, Non Executive Independent Director
Praneet Mishra, Non Executive Independent Director
Amit Koserwal, Non Executive Independent Director
Namita Sharma, Non Executive Women Director
Details
BSE 530119
NSE NULL
ISIN INE444D01016